Investor New Leaf Ventures II, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by New Leaf Ventures II, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2021-02-10 13G/A STIM / Neuronetics, Inc. 1,048,899 0
2020-02-13 13G/A STIM / Neuronetics, Inc. 1,048,899 1,048,899
2020-02-13 13G/A US74257L1089 / Principia Biopharma Inc. 943,248 943,248
2020-02-12 13G/A US74257L1089 / Principia Biopharma Inc. 2,657,748 943,248
2020-02-12 13G/A STIM / Neuronetics, Inc. 1,551,882 1,048,899
2019-02-13 13G STIM / Neuronetics, Inc. 1,551,882
2019-02-13 13G US74257L1089 / Principia Biopharma Inc. 2,657,748
2017-08-21 13G/A / Oxford Immunotec Global PLC
2017-07-06 13G/A IRTC / iRhythm Technologies, Inc. 1,813,978
2017-03-28 13D/A ARAV / Aravive, Inc. 2,039,223
2017-02-10 13G IRTC / iRhythm Technologies, Inc. 1,813,978
2016-11-15 13D/A ARAV / Aravive, Inc. 2,039,223 2,039,223
2015-04-14 13D/A ARAV / Aravive, Inc. 2,039,223
2015-03-31 13D/A MEIP / MEI Pharma, Inc. 2,100,000
2015-02-17 13G/A CMRX / Chimerix, Inc.
2014-11-19 13D/A DRTX / Durata Therapeutics Inc 0
2014-11-14 13D/A ARAV / Aravive, Inc. 2,559,374
2014-04-07 13D ARAV / Aravive, Inc. 3,371,930
2014-02-14 13G CMRX / Chimerix, Inc. 2,846,031
2014-02-14 13G / Oxford Immunotec Global PLC 1,377,497
2013-12-27 13G/A 02318X100 / Ambit Biosciences Corp
2013-11-27 13D/A MEIP / MEI Pharma, Inc. 3,780,475
2013-11-06 13D/A MEIP / MEI Pharma, Inc. 4,145,475
2013-05-24 13G 02318X100 / Ambit Biosciences Corp 1,250,000
2013-05-15 13D/A MEIP / MEI Pharma, Inc. 4,145,475
2013-03-01 13D/A MEIP / MEI Pharma, Inc. 4,602,775
2012-12-10 13D MEIP / MEI Pharma, Inc. 30,600,000
2012-08-13 13D/A 0
2012-08-01 13D DRTX / Durata Therapeutics Inc 3,028,439
2012-07-09 13D/A GEVA / Synageva Biopharma Corp 1,041,832
2012-03-28 13D/A GEVA / Synageva Biopharma Corp 1,371,609